Because of a production error, the recent article about adverse effects of antiretroviral therapy for HIV infection, by Valentina Montessori and associates,1 incorrectly stated that the authors had no competing interests. The correct statement appears here.
Competing interests: Valentina Montessori has received speaker fees from Abbott Laboratories, Agouron Pharmaceuticals Inc. and Roche for discussions on antiretroviral hepatotoxicity. Marianne Harris has consultancy agreements with Agouron Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc. and Bristol-Myers Squibb, and has received speaker fees or travel assistance (or both) from Agouron Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Roche and Merck Frosst Laboratories. Julio Montaner has received grants from, has served as an ad hoc advisor to or has spoken at events sponsored by Abbott Laboratories, Agouron Pharmaceuticals Inc., Shire Biochem Inc., Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, Glaxo Wellcome, Hoffmann-La Roche, Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pharmacia & Upjohn, and Trimeris Inc.
Reference
- 1.↵